Attention:
Card image cap

Vaccine Prioritization, Allocation, & Distribution: Law & Equity


Level: Beginner
Runtime: 92 minutes
Recorded Date: April 12, 2021
Click here to share this program
Printer-Friendly Version
Closed Caption

Agenda

• COVID-19 Variants and Vaccines
• Addressing Vaccine Prioritization, Allocation, and Distribution
        - Heaviness of History
        - Racial Equity in Vaccine Uptake
        - Hesitancy to Access
        - Vaccine Access Inequities
                 Local Issues
                Federal Policy Efforts
• Relevant Legal Authority
        - EEOC: Accommodations
        - Title VII - General
        - Title VII - Accommodations
        - OSHA
• Key Legal Considerations

Runtime: 1 hour, 32 minutes
Recorded: April 12, 2021
For NY - Difficulty Level: Newly admitted attorneys only (transitional)

Description

This seminar provides a broad overview of issues around prioritization, allocation, and distribution of the COVID-19 vaccines. The webinar addresses the state and local plans for prioritizing who gets the vaccine first and how it is distributed. The webinar also explores the employment law considerations with respect to the COVID-19 vaccine, including whether government and employers can require their constituencies or employees to get the vaccine, and the legal and medical bases for refusing to get the vaccine.

The seminar examines pressing questions about the vaccine and its allocation and provides some best practices for vaccine prioritization among government entities and health care providers.

This program was recorded on April 12th, 2021.

Provided By

American Bar Association
Card image cap

Panelists

Card image cap

Shannon Kathleen O'Fallon

Senior Assistant Attorney General
Oregon Department of Justice

Shannon O’Fallon, J.D., is a Senior Assistant Attorney General with the Oregon Department of Justice and graduated from the University of Oregon School of Law in 1993.

After law school Shannon moved to Alaska and worked for the Alaska Attorney General's Office for over seven years, representing both human services and natural resources agencies. She has been with the Oregon Department of Justice since April, 2002, and has advised the Public Health Division since 2004. Shannon has been advising the medical marijuana program since 2005 and has written most of the rules implementing the medical marijuana programs. In addition, Shannon has helped the Oregon Liquor Control Commission implement marijuana legalization since the passage of Measure 91 in 2014.

Card image cap

Muhammad Hamza Habib, MD

Medical Doctor, Oncology
Columbia University Herbert Irving Comprehensive Cancer Center

Muhammad Hamza Habib, MD is a medical doctor with experise in Medical Oncology and Pain Management at the Columbia University Herbert Irving Comprehensive Cancer Center.

Card image cap

Maria Fracassa Dwyer

Member
Clark Hill PLC

Maria Dwyer litigates employment and business cases and advises senior management in employment and business considerations. She also conducts workplace investigations and investigates and serves as a certified Hearing Officer in Title IX claims and counsels educational organizations in Title IX issues.

Maria advises clients across a wide range of industries including public and private employers and works with her clients to conduct workforce and senior management training, and to develop policies and strategies for workforce optimization.

Maria is the Member-In-Charge of Clark Hill’s, Detroit Office, is the Co-Practice Leader of the Food, Beverage and Hospitality Team, and a Co-Chair of Clark Hill BOLD – Detroit, the firm’s strategy to promote women within the firm, the legal profession, and the business community.

Maria is an ATIXA certified Title IX investigator and counsels universities and K-12 institutions in Title IX issues.

Maria is a member of the faculty of ICLE and is a frequent speaker on EEO and employment issues before various groups, including the State Bar of Michigan. She also advocates for prevention through education and specializes in training her clients’ workforces.

Card image cap

Nalini K. Pande

Managing Director
Sappho Health Strategies, LLC

Sappho Health Strategies, LLC's Managing Director, Nalini Pande, has nearly 25 years of experience in healthcare and health policy. She manages projects on health reform, health care systems, and health care delivery and design. Most recently she worked on an analysis of the different health reform proposals, including the public option, Medicare for All, the Medicare buy-in option and the Medicaid buy-in option. She has strong expertise in the Affordable Care Act, Medicare and Medicaid, health policy, patient safety, and emerging payment models, including accountable care organizations, bundled payments, and patient-centered medical homes.

Ms. Pande has significant experience in population health issues, quality measurement, health disparities, prevention, and health information technology. She also has considerable expertise in working with dual eligibles and the specific issues facing this unique population, such as coordination of benefits. Ms. Pande maintains a broad understanding of the challenges, barriers, and solutions to implementing integrated care models.

Ms. Pande has conducted numerous trainings and key informant interviews as well as facilitated focus groups. She previously led the Measure Applications Partnership (MAP) Coordinating Committee at NQF which focused on identifying measure sets for payment reform models, public reporting, and program evaluation in various settings such as clinician, hospital, post-acute care, and long-term care as well as for various populations including the dual eligible beneficiary population. She also served as an Adjunct Professor at Georgetown University's Department of Health Systems.

Ms. Pande is a graduate of Harvard Law School and Princeton's Woodrow Wilson School of Public Policy.

Card image cap

Montrece Ransom, JD, MPH

Team Lead for Public Health Law Training & Workforce Drvelopment
Centers for Disease Control and Prevention (CDC)

Montrece McNeill Ransom, JD, MPH currently serves as a Senior Public Health Analyst and Team Lead for Public Health Law Training and Workforce Development with the Public Health Law Program (PHLP) in the Office for State, Tribal, Local, and Territorial Support at the Centers for Disease Control and Prevention (CDC). Ms. Ransom began her career in 2001, as a Presidential Management Fellow (PMF). During her career she has directed the CDC Community Public Health Legal Preparedness Initiative, served as the lead coordinator for CDC’s annual Public Health Law Conference, and developed novel partnerships between CDC and the American Bar Association and the American Health Lawyers Association.

Currently, her primary focus is developing and delivering training aimed at increasing the capacity of public health practitioners across governmental levels to understand and use law to advance public health goals. She has presented trainings, taught courses, and published on a broad range of topics including public health emergency law, tribal public health law, health disparities, careers in public health, and environmental public health law. Ms. Ransom is a graduate of the University of Alabama School of Law and Emory University’s Rollins School of Public Health.

Ms. Ransom holds an undergraduate degree in Speech Communication from Columbus State University. She has earned Training Certification with the American Society of Training and Development, and also currently serves as Contributing Faculty with Walden University.


Card image cap

Similar Courses

Card image cap
55 minutes
Analyzing the Impact of U.S. Data Privacy Regulations
The discussion will focus on the latest developments with the California and other states’ privacy initiatives as well as the future of data privacy within the U.S. and how in-house counsel can prepare effectively. Specifically, our panelists will explore how to adapt your privacy operations and what is the scope of the application for each regulation.

General Counsel Conference

$65

Add to Cart
Card image cap
74 minutes
Anatomy of a Pharmaceutical Bankruptcy Case
This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
76 minutes
But I’m Afraid of Needles: The Sale of Health Care Assets
This panel will discuss various issues and challenges accompanying sales of health care assets, including factors to consider in determining whether or not a sale is the best alternative. Such factors include the role of regulatory authorities, political challenges, reimbursement issues, issues related to urban vs. rural facilities, the evolution of the health care business, and best practices in navigating such challenges.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
86 minutes
COVID-19 Relief Funding & Reopening America: What's Really Happening in Congress
Please join a distinguished panel who will share their thoughts on how best to safely and gradually re-open business across America.

American Bankruptcy Institute

$115

Add to Cart
Previous Next